Valencelabs
1 known investors
Valence Labs is an AI research engine that develops computational models to predict cellular responses to genetic and chemical interventions for drug discovery. The company focuses on building virtual cells to accelerate the identification of effective therapeutics.
Investors · 1
Competitors · 4
by search overlap
Valence17 shared keywordsValence builds AI-powered coaching and talent development tools for enterprise HR and talent leaders, aimed at developing employee judgment and skills as organizations adopt AI. Its offerings include an AI coaching product used for mentoring at scale and structured reflection in the workforce.
Valence Security11 shared keywordsValence provides a SaaS security platform that builds a complete inventory of sanctioned, unsanctioned, and shadow IT and AI applications, detecting risky integrations, OAuth tokens, service accounts, and non-SSO access. It is aimed at enterprise security teams to identify SaaS risks in real time and support compliance with SOC 2, ISO 27001, and GDPR.
Valence Ai10 shared keywordsValence builds an emotional communication layer for AI systems, aiming to give them functional emotional understanding by modeling not just intent but impact. The company focuses on AI alignment through emotionally intelligent, transparent, and human-guided technology.
Valencesurfacetech10 shared keywordsValence Surface Technologies is a full-service aerospace parts finishing company providing metal plating, chemical processing, shot peening, blasting, painting, and NDT inspection services for commercial aviation, defense, space, and medical applications. The company operates 12 facilities across North America with over 4,500 aerospace approvals and processes over 25 million parts annually.
Companies competing with Valencelabs for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Valencelabs do?
- Valence Labs is an AI research engine that develops computational models to predict cellular responses to genetic and chemical interventions for drug discovery. The company focuses on building virtual cells to accelerate the identification of effective therapeutics.
- Who are Valencelabs's investors?
- Valencelabs's investors include Fifty Years.